March 2018
Research Investigator
We are seeking a highly motivated bioinformatician to join our Translational Bioinformatics Immunoscience (IMS) and Small Molecule Immuno-Oncology (smIO) team. The successful candidate will help advance Bristol-Myers Squibb’s industry leading IMS and IO pipelines through [...]
November 2017
Epigenetic editing shows epigenetics as an early cancer-causing event
Unexpected findings in early-stage breast cancer initiation thanks to epigenetic editing. Research conducted at the Queen Mary University of London by Cancer Epigenetics Society Member, Dr. Gabriella Ficz and her collaborators, shows that an [...]
September 2017
Stephan Beck, Editor of Cancer Epigenetics
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Stephan Beck to the Editorial Board of Cancer Epigenetics. Dr. Stephan Beck is Professor of Medical Genomics at University College London Cancer [...]
Ayalew Tefferi, Editor of Clinical Cancer Epigenetics
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Ayalew Tefferi to the Editorial Board of Clinical Cancer Epigenetics. Dr. Tefferi is Professor of Hematology and of Internal Medicine at the [...]
July 2017
Owen O’Connor, Editor of Clinical Cancer Epigenetics
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Owen A. O'Connor to the Editorial Board of Clinical Cancer Epigenetics. Dr. O’Connor is Professor of Medicine and Experimental Therapeutics at Columbia [...]
Stephen Baylin elected to the National Academy of Sciences, USA
We are proud to announce that Prof. Stephen B. Baylin, Officer at the Cancer Epigenetics Society and Editor of Cancer Epigenetics, was elected to the National Academy of Sciences, USA. This distinction is in [...]